CytRx Corp. buy melinda
Start price
20.09.17
/
50%
€2.35
Target price
16.02.18
€3.61
Performance (%)
-39.85%
End price
16.02.18
€1.41
Summary
This prediction ended on 16.02.18 with a price of €1.41. The BUY prediction by melinda for CytRx Corp. performed very badly with a performance of -39.85%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
CytRx Corp. | - | - | - | - |
iShares Core DAX® | -0.543% | 1.491% | 13.638% | 16.760% |
iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% | 45.155% |
iShares Nikkei 225® | -2.863% | 2.491% | 12.078% | 7.840% |
iShares S&P 500 | -1.105% | 0.013% | 26.888% | 43.056% |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$
(Vom Mitglied beendet)